Abstract:Background: Saccharomyces cerevisiae (baker's yeast) has great potential as a whole-cell biocatalyst for multistep synthesis of various organic molecules. To date, however, few examples exist in the literature of the successful biosynthetic production of chemical compounds, in yeast, that do not exist in nature. Considering that more than 30% of all drugs on the market are purely chemical compounds, often produced by harsh synthetic chemistry or with very low yields, novel and environmentally sound production routes are highly desirable. Here, we explore the biosynthetic production of enantiomeric precursors of the anti-tuberculosis and anti-epilepsy drugs ethambutol, brivaracetam, and levetiracetam. To this end, we have generated heterologous biosynthetic pathways leading to the production of (S)-2-aminobutyric acid (ABA) and (S)-2-aminobutanol in baker's yeast. Results: We first designed a two-step heterologous pathway, starting with the endogenous amino acid L-threonine and leading to the production of enantiopure (S)-2-aminobutyric acid. The combination of Bacillus subtilis threonine deaminase and a mutated Escherichia coli glutamate dehydrogenase resulted in the intracellular accumulation of 0.40 mg/L of (S)-2-aminobutyric acid. The combination of a threonine deaminase from Solanum lycopersicum (tomato) with two copies of mutated glutamate dehydrogenase from E. coli resulted in the accumulation of comparable amounts of (S)-2-aminobutyric acid. Additional L-threonine feeding elevated (S)-2-aminobutyric acid production to more than 1.70 mg/L. Removing feedback inhibition of aspartate kinase HOM3, an enzyme involved in threonine biosynthesis in yeast, elevated (S)-2-aminobutyric acid biosynthesis to above 0.49 mg/L in cultures not receiving additional L-threonine. We ultimately extended the pathway from (S)-2-aminobutyric acid to (S)-2-aminobutanol by introducing two reductases and a phosphopantetheinyl transferase. The engineered strains produced up to 1.10 mg/L (S)-2-aminobutanol. Conclusions: Our results demonstrate the biosynthesis of (S)-2-aminobutyric acid and (S)-2-aminobutanol in yeast. To our knowledge this is the first time that the purely synthetic compound (S)-2-aminobutanol has been produced in vivo. This work paves the way to greener and more sustainable production of chemical entities hitherto inaccessible to synthetic biology.

Biosynthesis of -lactam nuclei in yeast

Biosynthesis of β-lactam nuclei in yeast

Construction Of A Controllable Beta-Carotene Biosynthetic Pathway By Decentralized Assembly Strategy In Saccharomyces Cerevisiae

Metabolic Engineering Strategies for De Novo Biosynthesis of Sterols and Steroids in Yeast.

Complete biosynthesis of noscapine and halogenated alkaloids in yeast

Natural and Engineered Biosynthesis of Nucleoside Antibiotics in Actinomycetes

Production of (S)-2-aminobutyric acid and (S)-2-aminobutanol in Saccharomyces cerevisiae

Combinatorial Biosynthesis, Metabolic Engineering and Mutasynthesis for the Generation of New Aminocoumarin Antibiotics

Technology development for natural product biosynthesis in Saccharomyces cerevisiae

Harnessing Synthetic Biology to Engineer Production and Secretion of Theanine in Saccharomyces Cerevisiae

Harnessing synthetic biology-based strategies for engineered biosynthesis of nucleoside natural products in actinobacteria

Construction of ajmalicine and sanguinarine de novo biosynthetic pathways using stable integration sites in yeast

Increased Cordycepin Production in Yarrowia Lipolytica Using Combinatorial Metabolic Engineering Strategies.

Generation of tetramycin B derivative with improved pharmacological property based on pathway engineering

Rational construction of a high-quality and high-efficiency biosynthetic system and fermentation optimization for A82846B based on combinatorial strategies in Amycolatopsis orientalis

De Novo Biosynthesis of Vindoline and Catharanthine in Saccharomyces cerevisiae

De novo production of protoberberine and benzophenanthridine alkaloids through metabolic engineering of yeast

Yeast Metabolic Engineering for Biosynthesis of Caffeic Acid-Derived Phenethyl Ester and Phenethyl Amide

Metabolic engineering of Saccharomyces cerevisiae for enhanced production of caffeic acid

Aided-efflux and high production of beta-amyrin realized by beta-cyclodextrin in situ synthesized on surface of Saccharomyces cerevisiae

Engineering yeast subcellular compartments for increased production of the lipophilic natural products ginsenosides